181 related articles for article (PubMed ID: 28902073)
1. Cryotherapy Reduces Progression of Cervical Intraepithelial Neoplasia Grade 1 in South African HIV-Infected Women: A Randomized, Controlled Trial.
Firnhaber C; Swarts A; Goeieman B; Rakhombe N; Mulongo M; Williamson AL; Michelow P; Ramotshela S; Faesen M; Levin S; Wilkin T
J Acquir Immune Defic Syndr; 2017 Dec; 76(5):532-538. PubMed ID: 28902073
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV-seropositive women from Johannesburg, South Africa.
Smith JS; Sanusi B; Swarts A; Faesen M; Levin S; Goeieman B; Ramotshela S; Rakhombe N; Williamson AL; Michelow P; Omar T; Hudgens MG; Firnhaber C
Am J Obstet Gynecol; 2017 Aug; 217(2):183.e1-183.e11. PubMed ID: 28366730
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
Wilkin T; Chen H; Sahasrabuddhe V; Matining R; Mngqibisa R; Chinula L; Mbilizi Y; Magure T; Omoz-Oarhe AE; Rassool M; Riviere C; Bhosale R; Godbole S; Naranjo R; Coombs R; Michelow P; Godfrey C; Firnhaber C
Clin Infect Dis; 2022 Oct; 75(8):1280-1288. PubMed ID: 35294524
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus Persistence and Association With Recurrent Cervical Intraepithelial Neoplasia After Cryotherapy vs Loop Electrosurgical Excision Procedure Among HIV-Positive Women: A Secondary Analysis of a Randomized Clinical Trial.
Chung MH; De Vuyst H; Greene SA; Mugo NR; Querec TD; Nyongesa-Malava E; Cagle A; Sakr SR; Luchters S; Temmerman M; Unger ER; McGrath CJ
JAMA Oncol; 2021 Oct; 7(10):1514-1520. PubMed ID: 34351377
[TBL] [Abstract][Full Text] [Related]
5. Human Papillomavirus Vaccination Prior to Loop Electroexcision Procedure Does Not Prevent Recurrent Cervical High-grade Squamous Intraepithelial Lesions in Women Living With Human Immunodeficiency Virus: A Randomized, Double-blind, Placebo-controlled Trial.
Firnhaber C; Swarts A; Jezile V; Mulongo M; Goeieman B; Williams S; Faesen M; Michelow P; Wilkin T
Clin Infect Dis; 2021 Oct; 73(7):e2211-e2216. PubMed ID: 32975556
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.
Denny L; Kuhn L; Hu CC; Tsai WY; Wright TC
J Natl Cancer Inst; 2010 Oct; 102(20):1557-67. PubMed ID: 20884893
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women.
Kuhn L; Wang C; Tsai WY; Wright TC; Denny L
AIDS; 2010 Oct; 24(16):2553-61. PubMed ID: 20706107
[TBL] [Abstract][Full Text] [Related]
8. Costs and cost-effectiveness of LEEP versus cryotherapy for treating cervical dysplasia among HIV-positive women in Johannesburg, South Africa.
Lince-Deroche N; van Rensburg C; Roseleur J; Sanusi B; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2018; 13(10):e0203921. PubMed ID: 30308014
[TBL] [Abstract][Full Text] [Related]
9. Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.
Omar T; Schwartz S; Hanrahan C; Modisenyane T; Tshabangu N; Golub JE; McIntyre JA; Gray GE; Mohapi L; Martinson NA
AIDS; 2011 Jan; 25(1):87-94. PubMed ID: 21076276
[TBL] [Abstract][Full Text] [Related]
10. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
11. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
[TBL] [Abstract][Full Text] [Related]
12. Cervical squamous intraepithelial lesions and associated cervical infections in an HIV-positive population in Rural Mpumalanga, South Africa.
Swanepoel PJ; Michelow P; Du Plessis R; Proudfoot IG; Tarr GA; Bockel SL; Swanepoel CJ
Cytopathology; 2013 Aug; 24(4):264-71. PubMed ID: 22817687
[TBL] [Abstract][Full Text] [Related]
13. Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
Videla S; Tarrats A; Ornelas A; Badia R; Castella E; Alcalde C; Chamorro A; Esté JA; Clotet B; Sirera G
Int J STD AIDS; 2019 Jan; 30(1):56-63. PubMed ID: 30170532
[TBL] [Abstract][Full Text] [Related]
14. Residual disease and HPV persistence after cryotherapy for cervical intraepithelial neoplasia grade 2/3 in HIV-positive women in Kenya.
De Vuyst H; Mugo NR; Franceschi S; McKenzie K; Tenet V; Njoroge J; Rana FS; Sakr SR; Snijders PJ; Chung MH
PLoS One; 2014; 9(10):e111037. PubMed ID: 25343563
[TBL] [Abstract][Full Text] [Related]
15. Low-grade squamous intraepithelial lesion on Papanicolaou test: follow-up rates and stratification of risk for high-grade squamous intraepithelial lesion.
Rufail M; Lew M; Pang J; Jing X; Heider A; Cantley RL
J Am Soc Cytopathol; 2020; 9(4):258-265. PubMed ID: 32402830
[TBL] [Abstract][Full Text] [Related]
16. HIV-Infected Women with Low-Grade Squamous Intraepithelial Lesion on Cervical Cytology Have Higher Risk of Underlying High-Grade Cervical Intraepithelial Neoplasia.
Sakdadech N; Muangmool T; Srisomboon J
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639509
[TBL] [Abstract][Full Text] [Related]
17. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study.
Moodley JR; Hoffman M; Carrara H; Allan BR; Cooper DD; Rosenberg L; Denny LE; Shapiro S; Williamson AL
BMC Cancer; 2006 May; 6():135. PubMed ID: 16719902
[TBL] [Abstract][Full Text] [Related]
18. Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.
Keller MJ; Burk RD; Xie X; Anastos K; Massad LS; Minkoff H; Xue X; D'Souza G; Watts DH; Levine AM; Castle PE; Colie C; Palefsky JM; Strickler HD
JAMA; 2012 Jul; 308(4):362-9. PubMed ID: 22820789
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and correlates of cervical squamous intraepithelial lesions among HIV-infected and uninfected women in Central Kenya.
Njagi SK; Ngure K; Mwaniki L; Kiptoo M; Mugo NR
Pan Afr Med J; 2021; 39():44. PubMed ID: 34422167
[TBL] [Abstract][Full Text] [Related]
20. Impact of timing of antiretroviral therapy initiation on survival of cervical squamous intraepithelial lesions: a cohort analysis from South Africa.
Zeier MD; Nachega JB; Van Der Merwe FH; Eshun-Wilson I; Van Schalkwyk M; La Grange M; Mason D; Louw M; Botha MH
Int J STD AIDS; 2012 Dec; 23(12):890-6. PubMed ID: 23258831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
